Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Radhakrishnan SV et al. | Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation. | 2015 | Biol. Blood Marrow Transplant. | pmid:25445642 |
| Williams KM et al. | Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation. | 2016 | Biol. Blood Marrow Transplant. | pmid:26475726 |
| Yadav H et al. | Azithromycin for the Treatment of Obliterative Bronchiolitis after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. | 2016 | Biol. Blood Marrow Transplant. | pmid:27575542 |
| Asano N et al. | Limited Azithromycin Localization to Rabbit Meibomian Glands Revealed by LC-MS-Based Bioanalysis and DESI Imaging. | 2017 | Biol. Pharm. Bull. | pmid:28867744 |
| Togami K et al. | Subcellular distribution of azithromycin and clarithromycin in rat alveolar macrophages (NR8383) in vitro. | 2013 | Biol. Pharm. Bull. | pmid:23995662 |
| Gilbert D and Gerber MA | Regarding "antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders". | 2005 | Biol. Psychiatry | pmid:16242119 |
| Budman C et al. | Regarding "antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders". | 2005 | Biol. Psychiatry | pmid:16242121 |
| Snider LA et al. | Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. | 2005 | Biol. Psychiatry | pmid:15820236 |
| Toti US et al. | Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles. | 2011 | Biomaterials | pmid:21652065 |
| Rivulgo V et al. | Comparative plasma exposure and lung distribution of two human use commercial azithromycin formulations assessed in murine model: a preclinical study. | 2013 | Biomed Res Int | pmid:24073402 |
| Liu F et al. | Sensitive liquid chromatography/mass spectrometry assay for the quantification of azithromycin in human plasma. | 2007 | Biomed. Chromatogr. | pmid:17604364 |
| Sharma K and Mullangi R | A concise review of HPLC, LC-MS and LC-MS/MS methods for determination of azithromycin in various biological matrices. | 2013 | Biomed. Chromatogr. | pmid:23553351 |
| Ben-Eltriki M et al. | A liquid chromatography-mass spectrometric method for the quantification of azithromycin in human plasma. | 2013 | Biomed. Chromatogr. | pmid:23494651 |
| Song Z and Wang C | Ultrasensitive assay of azithromycin in medicine and bio-fluids based on its enhanced luminol-H(2)O(2) chemiluminescence reaction using flow injection technique. | 2003 | Bioorg. Med. Chem. | pmid:14642581 |
| Miura T et al. | Novel azalides derived from 16-membered macrolides. Part II: Isolation of the linear 9-formylcarboxylic acid and its sequential macrocyclization with an amino alcohol or an azidoamine. | 2008 | Bioorg. Med. Chem. | pmid:18986810 |
| Jakopović IP et al. | Synthesis and properties of macrolones characterized by two ether bonds in the linker. | 2010 | Bioorg. Med. Chem. | pmid:20688524 |
| Kapić S et al. | 6-Alkylquinolone-3-carboxylic acid tethered to macrolides synthesis and antimicrobial profile. | 2010 | Bioorg. Med. Chem. | pmid:20673633 |
| Pavlović D and Mutak S | Synthesis and antibacterial evaluation of novel 4″-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens. | 2016 | Bioorg. Med. Chem. | pmid:26860929 |
| Kapić S et al. | Synthesis and activity of new macrolones: conjugates between 6(7)-(2'-aminoethyl)-amino-1-cyclopropyl-3-carboxylic acid (2'-hydroxyethyl) amides and 4″-propenoyl-azithromycin. | 2011 | Bioorg. Med. Chem. | pmid:22041174 |
| MaraÄić S et al. | 1,2,3-Triazole pharmacophore-based benzofused nitrogen/sulfur heterocycles with potential anti-Moraxella catarrhalis activity. | 2015 | Bioorg. Med. Chem. | pmid:26578325 |
| Hutinec A et al. | An automated, polymer-assisted strategy for the preparation of urea and thiourea derivatives of 15-membered azalides as potential antimalarial chemotherapeutics. | 2011 | Bioorg. Med. Chem. | pmid:21316974 |
| Washington AZ et al. | Exploiting translational stalling peptides in an effort to extend azithromycin interaction within the prokaryotic ribosome nascent peptide exit tunnel. | 2015 | Bioorg. Med. Chem. | pmid:26037612 |
| Wang Y et al. | Synthesis and antibacterial activity of novel 4″-O-(1-aralkyl-1,2,3-triazol-4-methyl-carbamoyl) azithromycin analogs. | 2017 | Bioorg. Med. Chem. Lett. | pmid:28655423 |
| Zhang L et al. | Design, synthesis and biological evaluation of azithromycin glycosyl derivatives as potential antibacterial agents. | 2013 | Bioorg. Med. Chem. Lett. | pmid:23937982 |
| Ma S et al. | Synthesis and antibacterial activity of 4'',11-di-O-arylalkylcarbamoyl azithromycin derivatives. | 2009 | Bioorg. Med. Chem. Lett. | pmid:19232491 |
| Denis A and Agouridas C | Synthesis of 6-O-methyl-azithromycin and its ketolide analogue via Beckmann rearrangement of 9(E)-6-O-methyl-erythromycin oxime. | 1998 | Bioorg. Med. Chem. Lett. | pmid:9873555 |
| Cheng H et al. | Synthesis and SAR of azalide 3,6-ketal aromatic derivatives as potent Gram-positive and Gram-negative antibacterial agents. | 2002 | Bioorg. Med. Chem. Lett. | pmid:12161150 |
| Ito S et al. | Effect of macrolide antibiotics on uptake of digoxin into rat liver. | 2007 | Biopharm Drug Dispos | pmid:17253595 |
| Fuksa L et al. | Amiodarone modulates pharmacokinetics of low-dose methotrexate in rats. | 2008 | Biopharm Drug Dispos | pmid:18548509 |
| Davila D et al. | Pharmacokinetics of azithromycin after single oral dosing of experimental animals. | 1991 | Biopharm Drug Dispos | pmid:1657238 |
| Togami K et al. | Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages. | 2011 | Biopharm Drug Dispos | pmid:21812004 |
| Najib NM et al. | Bioequivalence assessment of Azomycin (Julphar, UAE) as compared to Zithromax (Pfizer, USA)--two brands of azithromycin--in healthy human volunteers. | 2001 | Biopharm Drug Dispos | pmid:11745903 |
| Tayob N and Murray S | Nonparametric tests of treatment effect based on combined endpoints for mortality and recurrent events. | 2015 | Biostatistics | pmid:24719282 |
| Cameron ST | Patient-delivered partner therapy for chlamydia: a realistic public health measure in the UK. | 2009 | BJOG | pmid:19187365 |
| Melvin L et al. | Preferred strategies of men and women for managing chlamydial infection. | 2009 | BJOG | pmid:19187367 |
| Cameron ST et al. | Expedited partner therapy for Chlamydia trachomatis at the community pharmacy. | 2010 | BJOG | pmid:20497415 |
| Cameron ST et al. | Willingness of gynaecologists, doctors in family planning, GPs, practice nurses and pharmacists to adopt novel interventions for treating sexual partners of women with chlamydia. | 2007 | BJOG | pmid:17877773 |
| Heikkinen T et al. | The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. | 2000 | BJOG | pmid:10847234 |
| Muralidharan V and Striepen B | Teaching old drugs new tricks to stop malaria invasion in its tracks. | 2015 | BMC Biol. | pmid:26349580 |
| Wilson DW et al. | Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum. | 2015 | BMC Biol. | pmid:26187647 |
| van Bijnen EM et al. | Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community. | 2014 | BMC Fam Pract | pmid:25413920 |
| Silva FM et al. | Short-term triple therapy with azithromycin for Helicobacter pylori eradication: low cost, high compliance, but low efficacy. | 2008 | BMC Gastroenterol | pmid:18510773 |
| Lau A et al. | Treatment efficacy of azithromycin 1Â g single dose versus doxycycline 100Â mg twice daily for 7Â days for the treatment of rectal chlamydia among men who have sex with men - a double-blind randomised controlled trial protocol. | 2017 | BMC Infect. Dis. | pmid:28061753 |
| Goodhew EB et al. | Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration. | 2014 | BMC Infect. Dis. | pmid:24755001 |
| Dukers-Muijrers NH et al. | Design of the FemCure study: prospective multicentre study on the transmission of genital and extra-genital Chlamydia trachomatis infections in women receiving routine care. | 2016 | BMC Infect. Dis. | pmid:27502928 |
| Ab Rahman N et al. | Antibiotic prescribing in public and private practice: a cross-sectional study in primary care clinics in Malaysia. | 2016 | BMC Infect. Dis. | pmid:27188538 |
| Hu J et al. | Streptococcus pneumoniae and Haemophilus influenzae type b carriage in Chinese children aged 12-18 months in Shanghai, China: a cross-sectional study. | 2016 | BMC Infect. Dis. | pmid:27080523 |
| Unemo M | Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge. | 2015 | BMC Infect. Dis. | pmid:26293005 |
| Jensen JS and Bradshaw C | Management of Mycoplasma genitalium infections - can we hit a moving target? | 2015 | BMC Infect. Dis. | pmid:26286546 |
| Hoffmann K et al. | Prevalence and resistance patterns of commensal S. aureus in community-dwelling GP patients and socio-demographic associations. A cross-sectional study in the framework of the APRES-project in Austria. | 2015 | BMC Infect. Dis. | pmid:25981559 |